Mouth opening in systemic sclerosis: Its course over time, determinants and impact on mouth handicap.

IF 1.4 Q3 RHEUMATOLOGY Journal of Scleroderma and Related Disorders Pub Date : 2023-02-01 Epub Date: 2022-12-05 DOI:10.1177/23971983221138177
Sarah J H Khidir, Maaike Boonstra, Sytske Anne Bergstra, Gerry W M Boerrigter, Elles M Voogt-van der Harst, Maarten K Ninaber, Nina Ajmone Marsan, Tom W J Huizinga, Annette H M van der Helm-van Mil, Jeska K de Vries-Bouwstra
{"title":"Mouth opening in systemic sclerosis: Its course over time, determinants and impact on mouth handicap.","authors":"Sarah J H Khidir, Maaike Boonstra, Sytske Anne Bergstra, Gerry W M Boerrigter, Elles M Voogt-van der Harst, Maarten K Ninaber, Nina Ajmone Marsan, Tom W J Huizinga, Annette H M van der Helm-van Mil, Jeska K de Vries-Bouwstra","doi":"10.1177/23971983221138177","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>Decreased maximal mouth opening is a common and disabling manifestation in systemic sclerosis patients. We aimed to study the course of maximal mouth opening, determinants of smaller maximal mouth opening over time and the burden of smaller maximal mouth opening on mouth handicap.</p><p><strong>Methods: </strong>Consecutive systemic sclerosis patients participating in the prospective Leiden Combined Care in systemic sclerosis cohort were included. Annual clinical assessment included maximal mouth opening measurement and mouth handicap evaluation (Mouth Handicap in Systemic Sclerosis scale). Presence of microstomia (maximal mouth opening < 30 mm) was studied. Maximal mouth opening over time was assessed on group level and for all patients individually. Baseline characteristics were analysed for their association with smaller maximal mouth opening over time (linear mixed-effects models). Furthermore, cross-sectional association between maximal mouth opening with Mouth Handicap in Systemic Sclerosis scale was assessed (linear regression analysis).</p><p><strong>Results: </strong>A total of 382 systemic sclerosis patients were studied with median follow-up time of 2.0 years (interquartile range = 0.0-3.0). At baseline, mean maximal mouth opening was 42.2 ± 8.0 mm and 7% suffered from microstomia. Annual decrease of > 5.0 mm in maximal mouth opening during follow-up occurred in 63 patients and was accompanied by increase in disease severity. Disease characteristics at baseline independently predictive for smaller maximal mouth opening over time were: more extended skin subtype; peripheral vasculopathy; pulmonary, renal and gastrointestinal involvement. Smaller maximal mouth opening was significantly associated with more reported mouth handicap.</p><p><strong>Conclusion: </strong>The course of maximal mouth opening is stable in a majority of systemic sclerosis patients. Still, maximal mouth opening over time was smaller in patients with more severe organ involvement. Although microstomia was infrequent, a smaller maximal mouth opening was significantly associated with more mouth handicap, indicating the importance to address maximal mouth opening in routine care of systemic sclerosis patients.</p>","PeriodicalId":17036,"journal":{"name":"Journal of Scleroderma and Related Disorders","volume":null,"pages":null},"PeriodicalIF":1.4000,"publicationDate":"2023-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9896194/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Scleroderma and Related Disorders","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/23971983221138177","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2022/12/5 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"RHEUMATOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Objective: Decreased maximal mouth opening is a common and disabling manifestation in systemic sclerosis patients. We aimed to study the course of maximal mouth opening, determinants of smaller maximal mouth opening over time and the burden of smaller maximal mouth opening on mouth handicap.

Methods: Consecutive systemic sclerosis patients participating in the prospective Leiden Combined Care in systemic sclerosis cohort were included. Annual clinical assessment included maximal mouth opening measurement and mouth handicap evaluation (Mouth Handicap in Systemic Sclerosis scale). Presence of microstomia (maximal mouth opening < 30 mm) was studied. Maximal mouth opening over time was assessed on group level and for all patients individually. Baseline characteristics were analysed for their association with smaller maximal mouth opening over time (linear mixed-effects models). Furthermore, cross-sectional association between maximal mouth opening with Mouth Handicap in Systemic Sclerosis scale was assessed (linear regression analysis).

Results: A total of 382 systemic sclerosis patients were studied with median follow-up time of 2.0 years (interquartile range = 0.0-3.0). At baseline, mean maximal mouth opening was 42.2 ± 8.0 mm and 7% suffered from microstomia. Annual decrease of > 5.0 mm in maximal mouth opening during follow-up occurred in 63 patients and was accompanied by increase in disease severity. Disease characteristics at baseline independently predictive for smaller maximal mouth opening over time were: more extended skin subtype; peripheral vasculopathy; pulmonary, renal and gastrointestinal involvement. Smaller maximal mouth opening was significantly associated with more reported mouth handicap.

Conclusion: The course of maximal mouth opening is stable in a majority of systemic sclerosis patients. Still, maximal mouth opening over time was smaller in patients with more severe organ involvement. Although microstomia was infrequent, a smaller maximal mouth opening was significantly associated with more mouth handicap, indicating the importance to address maximal mouth opening in routine care of systemic sclerosis patients.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
系统性硬化症患者的张口情况:其随时间变化的过程、决定因素以及对张口障碍的影响。
目的:最大张口量减少是系统性硬化症患者常见的致残表现。我们旨在研究最大张口度的变化过程、最大张口度随时间变小的决定因素以及最大张口度变小对口腔残疾造成的负担:方法:纳入参与前瞻性莱顿系统性硬化症联合护理队列的连续系统性硬化症患者。年度临床评估包括最大张口度测量和口腔功能障碍评估(系统性硬化症口腔功能障碍量表)。是否存在小口畸形(最大张口度)?共研究了 382 名系统性硬化症患者,随访时间中位数为 2.0 年(四分位数间距 = 0.0-3.0)。基线时,平均最大张口量为 42.2 ± 8.0 毫米,7% 的患者患有小口畸形。在随访期间,63 名患者的最大口腔张开度每年下降 > 5.0 毫米,并且伴随着疾病严重程度的增加。基线时的疾病特征可独立预测随时间推移最大张口变小的情况:更广泛的皮肤亚型;外周血管病变;肺、肾和胃肠道受累。结论:最大张口量较小与更多的口腔残障报告明显相关:结论:大多数系统性硬化症患者的最大张口度是稳定的。结论:大多数系统性硬化症患者的最大口腔张开程度是稳定的,但在器官受累较严重的患者中,最大口腔张开程度随着时间的推移会变小。虽然小口畸形并不常见,但最大张口度越小与口腔障碍越多明显相关,这表明在系统性硬化症患者的日常护理中解决最大张口度问题非常重要。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
4.10
自引率
0.00%
发文量
31
期刊最新文献
Atypical morphoea, a herald of two malignancies: Lung adenocarcinoma and a neuroendocrine tumour. Changes in work and adequacy of financial resources during COVID-19 among people with systemic sclerosis: A Scleroderma Patient-centered Intervention Network study. Coronary artery calcification is prevalent in systemic sclerosis and is associated with adverse prognosis. N-terminal pro-brain natriuretic peptide is associated with pulmonary hypertension or diastolic dysfunction in patients with systemic sclerosis: An Australian prospective cross-sectional study. Views of nutrition needs in patients with systemic sclerosis.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1